These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Double-blind comparator trials with pinacidil, a potassium channel opener. Callaghan JT, Goldberg MR, Brunelle R. Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139 [Abstract] [Full Text] [Related]
4. Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin. Goldberg MR, Sushak CS, Rockhold FW, Thompson WL. Clin Pharmacol Ther; 1988 Jul; 44(1):78-92. PubMed ID: 3292105 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study. Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M. Clin Drug Investig; 2007 Jul; 27(8):545-58. PubMed ID: 17638395 [Abstract] [Full Text] [Related]
7. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation. Prisant LM, Carr AA, Nelson EB, Winer N, Velasquez MT, Gonasun LM. Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945 [Abstract] [Full Text] [Related]
8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
9. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension. Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S. Clin Ther; 1985 May; 7(2):199-204. PubMed ID: 3886142 [Abstract] [Full Text] [Related]
10. Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide. Corder CN, Goldberg MR, Alaupovic PA, Price MD, Furste SS. Eur J Clin Pharmacol; 1992 May; 42(1):65-70. PubMed ID: 1541318 [Abstract] [Full Text] [Related]
11. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group. Drugs; 1987 May; 34 Suppl 3():139-48. PubMed ID: 2894973 [Abstract] [Full Text] [Related]
12. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination. Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group. Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766 [Abstract] [Full Text] [Related]
14. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [Abstract] [Full Text] [Related]
16. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group. Fletcher AE, Battersby C, Adnitt P, Underwood N, Jurgensen HJ, Bulpitt CJ. J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618 [Abstract] [Full Text] [Related]
18. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial. Lacourcière Y, Lefebvre J, Poirier L, Archambault F, Arnott W. Am J Hypertens; 1994 Feb; 7(2):137-45. PubMed ID: 8179848 [Abstract] [Full Text] [Related]
19. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy. Abraham PA, Halstenson CE, Matzke GR, Keane WF. J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986 [Abstract] [Full Text] [Related]
20. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. Chrysant SG, Weber MA, Wang AC, Hinman DJ. Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]